Back

Select your region

Corporate

Europe:

Flag Albania Albania Flag Bosnia and Herzegovina Bosnia and Herzegovina Flag Bulgaria Bulgaria Flag Croatia Croatia Flag Cyprus Cyprus Flag Montenegro Montenegro Flag Czech Republic Czech Republic Flag Denmark Denmark Flag Estonia Estonia Flag Spain Spain Flag Kosovo Kosovo Flag Lithuania Lithuania Flag Latvia Latvia Flag Luxembourg Luxembourg Flag Macedonia Macedonia Flag Germany Germany Flag Poland Poland Flag Portugal Portugal Flag Romania Romania Flag Serbia Serbia Flag Slovakia Slovakia Flag Slovenia Slovenia Flag Switzerland Switzerland Flag Sweden Sweden Flag Turkey Turkey Flag Hungary Hungary Flag United Kingdom United Kingdom Flag Italy Italy

Asia:

Flag UAE UAE Flag Hong Kong Hong Kong Flag Kuwait Kuwait Flag Lebanon Lebanon

Africa:

Flag South Africa South Africa

Arrange a consultation about stem cells

Learn more

Get in touch with us today!

Would you like to find out more about our services? Fill out the form below and we will contact you as soon as possible to provide you with all the necessary information and answer your questions.

    We would like to point out that the personal data provided in the form will be processed by FamiCord Suisse, based in Switzerland (BusinessPark Zug Sumpfstrasse 26, 6302 Zug), for the purpose of contacting you by telephone in connection with the provision of service information.

    Image

    List of life saving
    transplantations

    List of uses for stem cells approved by the FamiCord Group’s laboratories:

    Image
    List of uses for stem cells approved by the FamiCord Group’s laboratories:
    Nr. Source Source type Diagnosis Medical sector Year of application Therapy Country Age of the recipient
    1801 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy Poland 67
    1802 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy Poland 65
    1803 Apheresis Allogeneic Myelodysplastic Syndrome + Myeloma Hematology 2024 Standard Therapy Germany 67
    1804 Apheresis Allogeneic Myelofibrosis Hematology 2024 Standard Therapy Poland 40
    1805 Apheresis Allogeneic Myelofibrosis Hematology 2024 Standard Therapy Poland 58
    1806 Apheresis Allogeneic Myelofibrosis Myeloid Metaplasia Hematology 2024 Standard Therapy Poland 60
    1807 Apheresis Allogeneic Myelofibrosis Post. Polycythemia Vera Hematology 2024 Standard Therapy Poland 66
    1808 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2024 Standard Therapy Poland 67
    1809 Apheresis Allogeneic Myeloma Hematology 2024 Standard Therapy Germany 65
    1810 Apheresis Allogeneic Myeloproliferative Neoplasms  Hematology 2024 Standard Therapy Poland 74
    1811 Apheresis Allogeneic Myeloproliferative Neoplasms/Myelodysplastic Syndrome Hematology 2024 Standard Therapy Poland 68
    1812 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2024 Standard Therapy Germany 23
    1813 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2024 Standard Therapy Germany 50
    1814 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2024 Standard Therapy Poland 50
    1815 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2024 Standard Therapy Germany 67
    1816 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2024 Standard Therapy Poland 46
    1817 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2024 Standard Therapy Poland 65
    1818 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2024 Standard Therapy Germany 66
    1819 Apheresis Autologous Non-Hodgkin Lymphoma – relapse Hematology 2024 Standard Therapy Germany 54
    1820 Apheresis Autologous Nonseminoma Hematology 2024 Standard Therapy Germany 38
    1821 Apheresis Allogeneic Osteomyelitis Hematology 2024 Standard Therapy Poland 65
    1822 Apheresis Allogeneic Post-Et-Myelofibrosis Hematology 2024 Standard Therapy Poland 59
    1823 Apheresis Allogeneic Post-Pv-Myelofibrosis Hematology 2024 Standard Therapy Poland 64
    1824 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2024 Standard Therapy Germany 60
    1825 Apheresis Allogeneic Primary Myelofibrosis Hematology 2024 Standard Therapy Poland 52
    1826 Apheresis Allogeneic Primary Myelofibrosis Hematology 2024 Standard Therapy Poland 67
    1827 Apheresis Allogeneic Primary Myelofibrosis Hematology 2024 Standard Therapy Poland 70
    1828 Apheresis Allogeneic Relapsed B-Cell Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 12
    1829 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy Poland 15
    1830 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy Poland 10
    1831 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy Poland 60
    1832 Apheresis Allogeneic Severe Aplastic Anemia Progressed To Myelodysplastic Syndrome Hematology 2024 Standard Therapy Poland 21
    1833 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 63
    1834 Apheresis Allogeneic Acute myeloid leukemia Hematology 2024 Standard Therapy Germany 64
    1835 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 56
    1836 Apheresis Autologous Hodgkin Lymphoma Hematology 2024 Standard Therapy Germany 56
    1837 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 64
    1838 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 56
    1839 Apheresis Autologous Follicular lymphoma Hematology 2024 Standard Therapy Germany 58
    1840 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 65
    1841 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 47
    1842 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 69
    1843 Apheresis Autologous Hodgkin Lymphoma Hematology 2024 Standard Therapy Germany 38
    1844 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 65
    1845 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 70
    1846 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 64
    1847 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 53
    1848 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 60
    1849 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 59
    1850 Apheresis Autologous Mantle cell lymphoma Hematology 2024 Standard Therapy Germany 45
    1851 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 66
    1852 Apheresis Autologous Hodgkin Lymphoma Hematology 2024 Standard Therapy Germany 33
    1853 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 64
    1854 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 59
    1855 Apheresis Allogeneic Primary myelofibrosis Hematology 2024 Standard Therapy Germany 55
    1856 Apheresis Allogeneic Acute myeloid leukemia Hematology 2024 Standard Therapy Germany 63
    1857 Apheresis Allogeneic Blastic Plasmacytoid Dendritic Hematology 2024 Standard Therapy USA 57
    1858 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 32
    1859 Apheresis Allogeneic Macrofocal multiple myeloma  Hematology 2024 Standard Therapy USA 75
    1860 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy United Kingdom 62
    1861 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy USA 52
    1862 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Germany 48
    1863 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy United Kingdom 71
    1864 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Romania 35
    1865 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Lithuania 47
    1866 Apheresis Allogeneic Diffuse large B-cell lymphoma Hematology 2024 Standard Therapy Australia 46
    1867 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy USA 65
    1868 Apheresis Allogeneic Chronic lymphatic leukemia Hematology 2024 Standard Therapy Norway 52
    1869 Apheresis Allogeneic Chronic myelogenous leukemia Hematology 2024 Standard Therapy Poland 60
    1870 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Hungary 32
    1871 Apheresis Allogeneic Malignant histiocytosis Hematology 2024 Standard Therapy Bulgaria 41
    1872 Apheresis Allogeneic Myelodysplastic syndrome Hematology 2024 Standard Therapy USA 78
    1873 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Hungary 20
    1874 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Italy 58
    1875 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy Portugal 67
    1876 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Italy 63
    1877 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Lithuania 19
    1878 Apheresis Allogeneic Hodgkin lymphoma Hematology 2024 Standard Therapy Russia 34
    1879 Apheresis Allogeneic chronic lymphocytic leukemia Richters Transformation Hematology 2024 Standard Therapy United Kingdom 68
    1880 Apheresis Allogeneic Myelodysplasia Hematology 2024 Standard Therapy Sweden 66
    1881 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Italy 52
    1882 Apheresis Allogeneic Myelodysplasia Hematology 2024 Standard Therapy Lithuania 70
    1883 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Germany 72
    1884 Apheresis Allogeneic plasma cell leukemia Hematology 2024 Standard Therapy USA 59
    1885 Apheresis Allogeneic Fibrolamellar Carcinoma Hematology 2024 Standard Therapy Czechia 41
    1886 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Italy 59
    1887 Apheresis Allogeneic post-ET Myelofibrose Hematology 2024 Standard Therapy Austria 61
    1888 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy USA 55
    1889 Apheresis Allogeneic Myeloma Multiplex Hematology 2024 Standard Therapy Poland 67
    1890 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Spain 45
    1891 Apheresis Allogeneic Myelofibrose Hematology 2024 Standard Therapy Spain 69
    1892 Apheresis Allogeneic Myelofibrose Hematology 2024 Standard Therapy Poland 60
    1893 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy USA 53
    1894 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy France 35
    1895 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Italy 69
    1896 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Norway 18
    1897 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Germany 51
    1898 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy Poland 62
    1899 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Hungary 56
    1900 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy USA 19